NO932815D0 - Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater - Google Patents

Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater

Info

Publication number
NO932815D0
NO932815D0 NO932815A NO932815A NO932815D0 NO 932815 D0 NO932815 D0 NO 932815D0 NO 932815 A NO932815 A NO 932815A NO 932815 A NO932815 A NO 932815A NO 932815 D0 NO932815 D0 NO 932815D0
Authority
NO
Norway
Prior art keywords
hydroxy
hydrogen
lipoxygenase
inhibiting
alkenyl
Prior art date
Application number
NO932815A
Other languages
English (en)
Other versions
NO932815L (no
Inventor
Rodney William Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO932815D0 publication Critical patent/NO932815D0/no
Publication of NO932815L publication Critical patent/NO932815L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
NO93932815A 1991-02-07 1993-08-06 Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater NO932815L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3016325A JPH0730061B2 (ja) 1991-02-07 1991-02-07 ヒドロキサム酸誘導体および組成物
PCT/US1992/000027 WO1992013848A1 (en) 1991-02-07 1992-01-08 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives

Publications (2)

Publication Number Publication Date
NO932815D0 true NO932815D0 (no) 1993-08-06
NO932815L NO932815L (no) 1993-08-09

Family

ID=11913313

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93932815A NO932815L (no) 1991-02-07 1993-08-06 Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater

Country Status (21)

Country Link
EP (1) EP0570401B1 (no)
JP (1) JPH0730061B2 (no)
KR (1) KR930703279A (no)
AT (1) ATE113942T1 (no)
AU (1) AU648872B2 (no)
CA (1) CA2101539A1 (no)
DE (1) DE69200665T2 (no)
DK (1) DK0570401T3 (no)
ES (1) ES2063578T3 (no)
FI (1) FI933492A0 (no)
HU (1) HUT65539A (no)
IE (1) IE920392A1 (no)
IL (1) IL100846A0 (no)
MX (1) MX9200519A (no)
MY (1) MY134478A (no)
NO (1) NO932815L (no)
NZ (1) NZ241530A (no)
PT (1) PT100093A (no)
TW (1) TW222627B (no)
WO (1) WO1992013848A1 (no)
ZA (1) ZA92862B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
WO1994001430A1 (en) 1992-07-13 1994-01-20 Cytomed, Inc. 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US6201016B1 (en) * 1994-06-27 2001-03-13 Cytomed Incorporated Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
WO1996000212A1 (en) * 1994-06-27 1996-01-04 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) * 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
MX9701042A (es) * 1996-02-07 1998-05-31 Pfizer Compuestos del acido hidroxamico.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1044308A (en) * 1964-04-28 1966-09-28 Langbein Pfanhauser Werke Ag Electrodeposition of bright copper
US3393209A (en) * 1965-10-04 1968-07-16 Dow Chemical Co Furfuryl and tetrahydrofurfuryl phenyl ureas
JPS5742632B2 (no) * 1972-12-25 1982-09-09
DE3882732T2 (de) * 1987-02-10 1993-12-02 Abbott Lab Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
GB2201008B (en) * 1987-02-12 1991-10-23 Stc Plc Optical fibre cables

Also Published As

Publication number Publication date
ES2063578T3 (es) 1995-01-01
IL100846A0 (en) 1992-11-15
ZA92862B (en) 1993-08-06
JPH04257571A (ja) 1992-09-11
AU648872B2 (en) 1994-05-05
MX9200519A (es) 1992-08-31
FI933492A (fi) 1993-08-06
ATE113942T1 (de) 1994-11-15
DK0570401T3 (da) 1994-12-05
KR930703279A (ko) 1993-11-29
NZ241530A (en) 1994-06-27
IE920392A1 (en) 1992-08-12
WO1992013848A1 (en) 1992-08-20
TW222627B (no) 1994-04-21
JPH0730061B2 (ja) 1995-04-05
PT100093A (pt) 1993-03-31
FI933492A0 (fi) 1993-08-06
HU9302283D0 (en) 1993-10-28
EP0570401A1 (en) 1993-11-24
MY134478A (en) 2007-12-31
DE69200665T2 (de) 1995-04-06
HUT65539A (en) 1994-06-28
NO932815L (no) 1993-08-09
EP0570401B1 (en) 1994-11-09
DE69200665D1 (de) 1994-12-15
CA2101539A1 (en) 1992-08-08
AU1173692A (en) 1992-09-07

Similar Documents

Publication Publication Date Title
FI955438A0 (fi) N-asyylisulfamidihappoesterit (tai -tioesterit), N-asyylisulfonamidit ja N-sulfonyylikarbamiinihappoesterit (tai -tioesterit) hyperkolesteroleemisina aineina
DE69108048D1 (de) Derivate von hydroxaminsäure und von n-hydroxyharnstoff sowie ihre verwendung.
PT734259E (pt) Utilizacao de derivados de piperidina para o tratamento da esquizofrenia
DK0640601T3 (da) Benzamidderivat
ATE318799T1 (de) Pyrrolderivate und medizinische zubereitung.
NO932815L (no) Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater
CA2174544A1 (en) Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents
EP0226536A3 (de) (Di)alkoxycarbonyl-amino-s-triazin-Derivate gegen tier- und pflanzenparasitäre Schädlinge
TR199801229T2 (xx) ''Metalopeptidaz inhibisyon aktivitesini havi tiol t�revleri
DE69522118D1 (de) Thiazolidonon- oder oxazolidinonderivate zur behandlung von angina pectoris und zusammensetzungen die diese als wirkstoffe enthält
FI932188A (fi) Oktahydronaftalenoximderivat foer inhibering av kolesterolbiosyntesen, deras framstaellning och anvaendning
BR9306762A (pt) Derivados indolinila anti-inflamatórios da n-hidroxiuréia e do ácido n-hidroxámico
DE3889820D1 (de) Sulfonamidderivate, Inhibitoren für das Aldose-Reduktase-Enzymsystem und diese enthaltende pharmazeutische Zusammenstellungen.
NZ514560A (en) Viral treatment